You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Roll-over study / extension study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Iptacopan)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Brno - Bohunice, Czechia
  • +30 more
Jul 29, 2022

Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

Enrolling by invitation
  • Primary Hyperoxaluria Type 1 (PH1)
  • +5 more
  • San Francisco, California
  • +19 more
Jun 22, 2022

Cancer Trial (Osimertinib)

Not yet recruiting
  • Cancer
  • (no location specified)
Nov 17, 2022

Ascites, Peritoneal Carcinomatosis, Peritoneum Tumor Trial in Chandigarh (Standard Paracentesis, Roll Over Paracentesis)

Terminated
  • Ascites
  • +3 more
  • Standard Paracentesis
  • Roll Over Paracentesis
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Mar 2, 2022

Polycystic Kidney Disease, Adult Trial in Bethlehem (Lixivaptan)

Active, not recruiting
  • Polycystic Kidney Disease, Adult
  • Bethlehem, Pennsylvania
    Northeast Clinical Research Center, LLC
Jun 7, 2022

Acute Lymphoblastic Leukemia Trial in Russian Federation (Lyophilized S95014)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lyophilized S95014
  • Chelyabinsk, Russian Federation
  • +5 more
Apr 25, 2022

Cancer Trial in St. Gallen (Rogaratinib (BAY1163877), Combination drug)

Completed
  • Cancer
  • Rogaratinib (BAY1163877)
  • Combination drug
  • St. Gallen, Sankt Gallen, Switzerland
    Kantonsspital St. Gallen
Mar 20, 2022

Human Immunodeficiency Virus Type 1 Trial in Worldwide (Rilpivirine)

Recruiting
  • Human Immunodeficiency Virus Type 1
  • Brescia, Italy
  • +13 more
Jan 17, 2023

MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • (no location specified)
Aug 5, 2022

Endogenous Cushing Syndrome Trial in Edmonton, Halifax, Sherbrooke (Intervention/Treatment)

Active, not recruiting
  • Endogenous Cushing Syndrome
  • Edmonton, Alberta, Canada
  • +2 more
Nov 9, 2023

ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

Not yet recruiting
  • HIV Infections
    • (no location specified)
    Jan 9, 2023

    Autoimmunity, Inflammation Trial in Worldwide (Secukinumab s.c. injection)

    Recruiting
    • Autoimmunity, Inflammation
    • Secukinumab s.c. injection
    • Fullerton, California
    • +93 more
    Jul 14, 2022

    NSCLC, Urothelial Carcinoma Trial in Worldwide (Durvalumab)

    Enrolling by invitation
    • Non-Small Cell Lung Cancer
    • Urothelial Carcinoma
    • Newmarket, Ontario, Canada
    • +26 more
    Aug 2, 2022

    Bronchiectasis Trial (BI 1291583, Placebo matching BI 1291583)

    Not yet recruiting
    • Bronchiectasis
    • BI 1291583
    • Placebo matching BI 1291583
    • (no location specified)
    Apr 26, 2023

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Asciminib single agent
    • +5 more
    • Ann Arbor, Michigan
    • +49 more
    Jan 26, 2023

    Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

    Active, not recruiting
    • Myelofibrosis
    • Long-term Follow-up
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Lip Augmentation Trial in United States (PN40082)

    Terminated
    Has Results
    • Lip Augmentation
    • PN40082
    • Encinitas, California
    • +4 more
    Jul 28, 2021

    Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

    Recruiting
    • Diffuse Astrocytoma
    • +22 more
    • Phoenix, Arizona
    • +26 more
    Jan 27, 2023

    HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • Aurora, Colorado
    • +2 more
    Dec 29, 2022

    Aging, Mild Cognitive Impairment, Aging Well Trial in Champaign, Chicago (OneClick Social Engagement Intervention, OneClick

    Recruiting
    • Aging
    • +2 more
    • OneClick Social Engagement Intervention
    • OneClick Social Engagement Intervention Extension
    • Champaign, Illinois
    • +1 more
    May 12, 2022

    Congenital Adrenal Hyperplasia Trial run by the (Chronocort)

    Not yet recruiting
    • Congenital Adrenal Hyperplasia
    • Bethesda, Maryland
      National Institutes of Health Center
    Mar 18, 2022

    Cancer - Ovarian Trial (Veliparib, capsule, Veliparib, tablet, Carboplatin)

    Withdrawn
    • Cancer - Ovarian
    • Veliparib, capsule
    • +3 more
    • (no location specified)
    Dec 6, 2021

    Parkinson Disease, Constipation Trial in United States (Active Investigational Treatment ENT-01)

    Completed
    • Parkinson Disease
    • Constipation
    • Active Investigational Treatment ENT-01
    • Fountain Valley, California
    • +17 more
    Mar 21, 2022

    HIV Trial in Puerto Rico, United States (Ritonavir, Nelfinavir mesylate, Efavirenz)

    Completed
    • HIV Infections
    • Chicago, Illinois
    • +5 more
    Oct 28, 2021

    Knee Osteoarthritis Trial in United States (Home-based Neuromuscular Electrical Stimulation (NMES) therapy)

    Completed
    • Knee Osteoarthritis
    • Home-based Neuromuscular Electrical Stimulation (NMES) therapy
    • Tucson, Arizona
    • +4 more
    Mar 16, 2021